Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Comparison of various combinations of anti HEV IgM and IgG among HIV positive subjects and Blood Donors

From: Prevalence and risk of hepatitis E virus infection in the HIV population of Nepal

Anti HEV antibodies IgM+/IgG+ IgM+/IgG- IgM−/IgG+ IgM−/IgG- HEV RNA+
Blood Donors 9(1.5%) 18(3.1) 47(8.1) 507(87.3) 9(1.5%)
HIV positive Subjects 17(3.7%) 53(11.5%) 164(35.7%) 225(49%) 17(3.7%)